Roche and Dualitas Therapeutics announce research collaboration worth up to $1bn
The two companies aim to discover and develop novel bispecific antibodies for immunology and inflammation diseases
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Roche and Dualitas Therapeutics announce research collaboration worth up to $1bn
The two companies aim to discover and develop novel bispecific antibodies for immunology and inflammation diseases
Lilly to acquire Merida Biosciences in deal worth up to $2.875bn
The acquisition is to advance treatments for serious autoimmune and allergic diseases
J&J’s Darzalex combination treatment for untreated multiple myeloma recommended by NICE
Around 33,000 people in the UK are currently living with multiple myeloma, an incurable type of blood cancer
Gilead and PAHO announce milestone partnership to accelerate access to HIV pre-exposure treatment
The agreement will improve access to twice-yearly Lenacapavir across Latin America and the Caribbean
CPHI Milan introduces new specialist zones
The event runs from 6-8 October 2026 at the Fiera Milano exhibition centre in Rho, Italy
Latest content
Frontera Global appoints Steph Wasek as General Manager and Mohammed Saleh Bham as Director of Growth
Wasek was previously at Synergy Vision and Bham joins from Massive Wave Research
Read More
Chiesi appoints David Khougazian as Group CEO
Khougazian most recently served as Executive Partner, Growth, and Head of Global Engagement at Flagship Pioneering
Read More
Inizio appoints Oisín Ó Gógáin as Chief People Officer
Ó Gógáin was most recently Aon’s Chief People Officer for the UK, Ireland and South Africa
Read More
Langland appoints Kathryn Stewart as Head of Strategy and promotes Diane Ross to Head of Scientific Practice
Stewart previously held roles at Saatchi & Saatchi Health London, part of the Publicis Health network, and Avalere, while Ross has been part of Publicis Health for over two decades
Read More
Intelligence
Cell and gene therapies – moving from niche innovations towards broader clinical use
Looking at the regulatory challenges of cell and gene therapies for serious or life-threatening rare diseases
Read More
Creating a strong patent portfolio through constant communication
Why patenting should not stop at the drug candidate stage – and why coordination between researchers and attorneys is essential for strong protection
Read More
Leading through complexity
Strengthening strategic judgement during uncertainty – exploring the strategic concepts that matter most
Read More
The Amazon reckoning: GLP-1s and the consumer lifestyle shift – why the molecule is no longer enough
Amazon’s entry into the GLP-1 market should be a signal to pharma that it needs to shift focus from molecule to ‘Operating Model’
Read More
Lupus – moving patient care beyond current therapies towards resetting the immune system
Precision medicine is no longer theoretical, but increasingly achievable for people living with lupus
Read More
Forging a connection through creativity
A spark of creativity can cut through complexity, adding real value and helping to forge true connections with patients
Read More
Blogs
Latest
Pharma-Exclusive Webinar: Redefining Engagement in the AI Era
September 17, 2026 | Impetus Digital|AI, AI compliance, AI for life sciences, AI for pharma, HCP engagement, HCP training, Impetus Digital, KOL Engagement, Pharma trends, artificial intelligence, kol education, life sciences, patient engagement, pharma AI, webinar
Join Impetus Digital’s pharma-exclusive webinar to discover how compliant AI tools and virtual workflows can elevate static programs into high-retention, interactive experiences without enterprise overhead.
The Pulse of AI Innovation: From More Data to Better Care
September 17, 2026 | Medscape Education|
At the European Society of Cardiology (ESC) Congress, two of cardiology’s most influential voices sat down to talk about artificial intelligence at Medscape’s ‘The Pulse …
Governor Josh Stein marks strengthening North Carolina-Ireland trade relationship at Uniphar facility visit
September 16, 2026 | Uniphar|
The event speaker panel, from left to right: Brian Kiefel, Ireland Site Leader & CTO, Honeywell; Christopher Chung, Chief Executive Officer, EDPNC; Tom Scrivener, Group …
Next-Level Clinical Practice, Real-World Impact: Evolving Patient Simulation with the Clinical Readiness Studio
September 15, 2026 | Medscape Education|AI, CME, Clinical Readiness Studio, HcSimWeek, Health Simulation Week, MedEd
Healthcare is changing rapidly, bringing unprecedented data and complex treatment pathways to the point of care. Clinical mastery requires active experience, the confidence to make …
Medscape Sponsors The John Ritter Foundation’s “Evening From the Heart”
September 15, 2026 | Medscape Education|Aortic Dissection Awareness Week, Cardiology Education, Evening from the Heart, John Ritter Foundation for Aortic Health
When independent, evidence-based education directly connects with clinicians at the point of care, clinical practice changes. Driven by this vital mission, Medscape Education was proud …
The Power of Plurality
September 16, 2026 | 11 London|AI governance & trust, AI in pharma marketing, HCP engagement, Patient insight, agency transformation, healthcare communications
A thought piece on plurality of voice, and rewiring the advertising agency of the modern age
When what matters to patients is hard to measure
September 15, 2026 | Cuttsy + Cuttsy|EU HTA, JCA, JSC, Joint Clinical Assessment, Joint Scientific Consultation, clinical trials
Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to look beyond what traditional clinical …
Why phase 2 decisions are locking out pharma’s best launch positions
September 14, 2026 | Nmblr|Commercialisation strategy, Launch Performance, Success Factors, pharma launch, phase 2, positioning, value proposition
Half of the 2023 US pharmaceutical launch class missed pre-launch first-year forecasts . That gap is usually explained away as a data problem, a market …
Intelligent Commercialization™ across the pharma lifecycle
August 27, 2026 | Inizio|Intelligent Commercialization, Pharma, healthcare
Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.
Four steps to a smarter congress strategy: A practical guidebook
August 27, 2026 | Inizio|Intelligent Congress, Pharma, healthcare
This guidebook explores how Intelligent Congress helps pharma teams create more coordinated, measurable, and impactful congress strategies.